Graduate School of Business
1101 East 58th Street
1050 Massachusetts Avenue
Cambridge, MA 02138
University of Chicago
in Total Papers Downloads
in Total Papers Citations
Health economics, Health care spending, Medical innovation, Risk premium
Healthcare Finance, R&D Investments, Drug Development, FDA Approval, Idiosyncratic Risk, Risk sharing, Hedging
This is a National Bureau of Economic Research Paper. NBER charges a fee of
$5.00 for this paper.
File name: nber.
If you wish to purchase the right to make copies of this paper for distribution to others, please select the quantity.
Health Economics, Terminal Care, Health Spending
patent law, between-patent competition, within-patent competition, pharmaceuticals, pharmaceutical industry, generic drugs,research and development costs, R&D, Federal Drug Administration, FDA
National Accounts, Health Economics, Macroeconomics
Comparative, Effectiveness, Research
Medical Innovations, Pricing, Quality
Medical R&D, Research & Development, Health Economics
health care, health markets, medicine
Cookies are used by this site. To decline or learn more, visit our Cookies page.
This page was processed by apollobot1 in 2.149 seconds